日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research

远程医疗与面对面知情同意在临床癌症研究中的质量比较

Sternschuss, Michal; Lattanzi, Michael; Vertosick, Emily; Austria, Mia; Martin, Sené; Regazzi, Ashley; Buckely, Michael T; Lengfellner, Joseph; Riely, Gregory J; Solit, David B; Rosenberg, Jonathan E; Iyer, Gopa; Stetson, Peter D; Morris, Michael J; Vickers, Andrew J; Funt, Samuel A

Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma

在既往接受过恩福妥单抗治疗的转移性尿路上皮癌患者中,沙妥珠单抗戈维替康的真实世界临床疗效

Sternschuss, M; Toumbacaris, N; Das, J P; Powles, T; Kotecha, R R; Laccetti, A L; Xiao, H; Feld, E; McHugh, D J; Keegan, N M; Bajorin, D F; Funt, S A; Shah, N J; Iyer, G; Aggen, D H; Teo, M Y; Ostrovnaya, I; Rosenberg, J E

Enfortumab vedotin and pembrolizumab: redefining the standard of care for previously untreated advanced urothelial cancer

Enfortumab vedotin 和 pembrolizumab:重新定义既往未接受治疗的晚期尿路上皮癌的标准治疗方案

Sternschuss, Michal; Rosenberg, Jonathan E

Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool

结直肠癌肝转移生物标志物表征及其作为预后工具的应用

Michal, Sternschuss; Tal, Goshen-Lago; Gali, Perl; Miki, Goldenfeld; Elana, Brook; Baroch, Brenner; Hanoch, Kashtan; Irit, Ben Aharon; Riad, Haddad

Efficacy and safety of neoadjuvant immune checkpoint inhibitors in early-stage triple-negative breast cancer: a systematic review and meta-analysis

新辅助免疫检查点抑制剂治疗早期三阴性乳腺癌的疗效和安全性:系统评价和荟萃分析

Sternschuss, Michal; Yerushalmi, Rinat; Saleh, Ramy R; Amir, Eitan; Goldvaser, Hadar

Efficacy of immune-checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta-analysis

免疫检查点抑制剂治疗转移性胃癌或胃食管交界处腺癌的疗效按患者亚组进行分析:系统评价和荟萃分析

Kundel, Yulia; Sternschuss, Michal; Moore, Assaf; Perl, Gali; Brenner, Baruch; Goldvaser, Hadar

Can Ipilimumab restore immune response in advanced NSCLC after progression on anti-PD-1/PD-L1 agents?

在接受抗PD-1/PD-L1药物治疗后病情进展的晚期非小细胞肺癌患者中,伊匹木单抗能否恢复免疫反应?

Sternschuss, Michal; Peled, Nir; Allen, Aaron M; Dudnik, Elizabeth; Rotem, Ofer; Kurman, Noga; Gal, Omer; Reches, Hiba; Zer, Alona

Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location

侧别很重要:替代生物标志物可根据解剖位置预测结直肠癌的预后

Ben-Aharon, Irit; Goshen-Lago, Tal; Sternschuss, Michal; Morgenstern, Sara; Geva, Ravit; Beny, Alexander; Dror, Ygael; Steiner, Mariana; Hubert, Ayala; Idelevich, Efraim; Shulman, Katerina; Mishaeli, Moshe; Man, Sophia; Liebermann, Nicky; Soussan-Gutman, Lior; Brenner, Baruch